ACAD
ACADIA Pharmaceuticals Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +7.1% ·
Aktienfluss +12.0% ·
neue Nettopositionen +6.7%
— Formel
Breite Akkumulation — steigende Anteile bei mehr Haltern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q4 2024
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 122 | +9 | 90.95M | $2.30B | +11 | −1 |
| Q1 2026 | 115 | -3 | 85.30M | $1.90B | +4 | −8 |
| Q4 2025 | 119 | 0 | 93.96M | $2.51B | +1 | — |
| Q3 2025 | 23 | +1 | 66.53M | $1.42B | +1 | −1 |
| Q2 2025 | 20 | +2 | 61.51M | $1.33B | +2 | — |
| Q1 2025 | 15 | 0 | 22.54M | $374.41M | — | — |
| Q4 2024 | 15 | +1 | 20.32M | $372.93M | +1 | — |
| Q3 2024 | 13 | -1 | 13.63M | $209.57M | — | −1 |
| Q2 2024 | 14 | — | 19.35M | $314.37M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passiv) | 4.52M | — | $82.97M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | D. E. Shaw & Co. ✦ | 3.24M | -7.5% | $59.48M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 3 | D. E. Shaw & Co. ✦ | 3.24M | -7.5% | $59.48M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passiv) | 2.88M | +0.1% | $52.81M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passiv) | 2.88M | +0.1% | $52.81M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Point72 Asset Management ✦ | 2.23M | Neu | $40.94M | 0.1% | New | 1 | SEC ↗ |
| 7 | Norges Bank ✦ (passiv) | 1.39M | +4.5% | $25.55M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Two Sigma Investments ✦ | 1.24M | +12.0% | $22.82M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 9 | Renaissance Technologies ✦ | 1.23M | +204.2% | $22.51M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Millennium Management ✦ | 1.12M | -45.5% | $20.52M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Marshall Wace ✦ | 993.59K | -16.4% | $18.23M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Marshall Wace ✦ | 993.59K | -16.4% | $18.23M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 621.01K | -5.9% | $11.40M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 621.01K | -5.9% | $11.40M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 337.87K | +101.6% | $6.20M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 337.87K | +101.6% | $6.20M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Fisher Asset Management ✦ | 327.50K | +68.3% | $6.01M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 69.97K | +95.8% | $1.28M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 65.18K | +76.5% | $1.20M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 65.18K | +76.5% | $1.20M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 65.18K | +76.5% | $1.20M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | Wellington Management ✦ | 55.71K | -11.0% | $1.02M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 23 | Wellington Management ✦ | 55.71K | -11.0% | $1.02M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 24 | Wellington Management ✦ | 55.71K | -11.0% | $1.02M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 25 | Wellington Management ✦ | 55.71K | -11.0% | $1.02M | 0.0% | ▼ Trim | 3 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Point72 Asset Management | $40.94M | 0.1% |
Ausgestiegen
| Keine erfassten Ausstiege in diesem Quartal. |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 337 Inhaber, 164.47M Anteile, $3.62B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.